Low Molecular Weight Heparins Inhibit Cyclooxygenase-2 Expression in Human Hepatocarcinoma Implanted in Nude Mice

YUAN Ke-li,WANG Yu,ZHENG Qi,YAN Jun
DOI: https://doi.org/10.3969/j.issn.1002-266x.2006.26.006
2006-01-01
Abstract:[Objective] To study effects of low molecular weight heparins on cyclooxygenase-2(COX-2) of hepatocarcinoma in vivo.[Methods] Metastatic model simulating human hepatocarcinoma was established by orthotopic implantation of human tumor tissue into nude mice.Then were randomly submitted into different treatment groups: control group with saline solution,chemotherapy group with 5-Fu and CDDP i.p.,Fragmin group(subcutaneous injection),combination group.After 7 weeks of treatment,tumor volume,inhibitive rates,intratumoral microvessel density(MVD),vascular endothelial growth factor(VEGF),COX-2 and AFP.[Results] Compared with control group,implanted tumors were significantly reduced in weight in chemotherapy,Fragmin and combination groups with corresponding inhibition rates 91.63%,69.40% and(71.10%) respectively.MVD decreased significantly in Fragmin and combination groups(4.83±1.83 and 6.50±(2.35)),and there was no significant difference between chemotherapy and control group.VEGF,COX-2 staining and AFP level were significantly reduced in cancer tissue in Fragmin group and combined treatment group compared with the chemotherapy and control group.The growth of human hepatocarcinoma implanted in nude mice was inhibited in Fragmin group and combined treatment group compared with chemotherapy,but the difference had no statistical significance.[Conclusion] Low molecular weight heparins(Fragmin) can inhibit growth hepatocarcinoma,possibly through inhibiting tumor angiogenesis.And Low molecular weight heparins maybe inhibit tumor angiogenesis by inhibiting COX-2 expression.
What problem does this paper attempt to address?